Smiths Group/£SMIN

1D1W1MYTD1Y5YMAX

About Smiths Group

Smiths Group is a British multinational company headquartered in London, United Kingdom. It operates in the engineering sector with a focus on designing, manufacturing, and delivering products and services for various industries, including energy, security, general industrial, and healthcare markets. Key segments include John Crane, providing products for energy and process industries; Smiths Detection, specializing in threat detection and protection; and Smiths Medical, offering medical devices and equipment. Established in 1851, Smiths Group has a global footprint, serving customers in over 50 countries. The company emphasizes innovation and technical expertise as part of its strategic positioning, contributing to its long-standing presence in diverse yet technologically driven markets.
Ticker
£SMIN
Primary listing
LSE
Employees
15,650

Smiths Group Metrics

BasicAdvanced
£8.3B
4.49
£6.26
0.74
£0.47
1.66%

What the Analysts think about Smiths Group

Analyst ratings (Buy, Hold, Sell) for Smiths Group stock.
Analyst projections of the future price of Smiths Group stock.

Bulls say / Bears say

The portfolio overhaul has turned Smiths into a more focused industrial group and raised £3.3bn from selling Detection and Interconnect. It ended FY2026 with £1.75bn of net cash and had completed a £1.5bn buyback, giving shareholders a substantial return of capital and management more flexibility. (Smiths Group, Reuters)
Smiths exceeded expectations with FY2026 headline operating profit of £399m and lifted its margin to 20.6%. Management expects roughly 4% organic growth and a margin around 21% in FY2027, supported by a robust order book and ongoing efficiency savings. (Reuters, Smiths Group)
The remaining businesses have new exposure to potentially attractive growth areas. DRC Heat Transfer adds data-centre cooling, while energy-security spending supports John Crane; Flex-Tek’s aerospace strength also partly offset weaker construction and thermal markets in FY2026. (Smiths Group, Smiths Group)
Underlying growth is still modest relative to the long-term ambition. FY2026 organic revenue growth was only 1.2%, while FY2027 guidance of about 4% remains below Smiths’ 5% to 7% medium-term target. (Smiths Group, Reuters)
After selling Detection and Interconnect, Smiths is more dependent on John Crane and Flex-Tek, leaving it exposed to energy, industrial and construction cycles. Flex-Tek’s FY2026 organic revenue fell 0.4%, while John Crane absorbed about £20m of Middle East disruption. (Smiths Group, Smiths Group)
Smiths has only just begun a process to transfer its legacy US asbestos liability, so the outcome and timing are uncertain. Until it is completed, the liability remains an execution and potential cash-flow risk alongside the wider demands of integrating DRC and reshaping the group. (Reuters, Smiths Group)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.

Smiths Group Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Smiths Group Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.